People · Operator
Named in public records as an officer, director or promoter · active 2016–2021 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Inflammatix, Inc. | — | Biotechnology | Series D+ | $134.5M | $3.3B | 2020 |
| All Set Works, Inc. | — | Other Technology | Series A | $14.4M | $400.8M | 2016 |
TIMOTHY SWEENEY at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside TIMOTHY SWEENEY on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Shanahan | 1 | 8 |
| Michael Rubin | 1 | 8 |
| John Reardon | 1 | 7 |
| Justin Kao | 1 | 4 |
| Steven Tablak | 1 | 2 |
| Ann Stanberry | 1 | 1 |
| Anthony Storm | 1 | 1 |
| Mark Touhey | 1 | 1 |
| Julie Haase | 1 | 1 |
| KENNETH BAHK | 1 | 1 |
| DAVID PERSING | 1 | 1 |
| JONATHAN ROMANOWSKY | 1 | 1 |
| Matthew Nickerson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.